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Reconstructed interfollicular feline 
epidermis as a model for the screening 
of drugs against Microsporum canis
B. MIGNON, J. TABART, A. BALDO, 
S. VERMOUT and B. LOSSON
University of Liège, Faculty of Veterinary Medicine, Liege, 
Belgium 
A fully differentiated reconstructed interfollicular feline
epidermis (RFE) was recently developed in vitro and was
demonstrated to be relevant for studying Microsporum
canis–epidermis interactions. The aim of this study was to
investigate whether RFE could be an adequate model for
in vitro screening of drugs against M. canis. As a preliminary
step, the minimum inhibitory concentration of miconazole
nitrate against M. canis IHEM 21239 was determined to be
0.3 mg L−1 on Sabouraud’s dextrose agar. Reconstructed
feline epidermis grown at the air–liquid interface were
cultured for 24 h in RFE culture medium without antibiotics
but supplemented with miconazole (range 0.1–1 mg L−1)
or its solubilizing agent, dimethylsulfoxide. Then, RFE were
inoculated in triplicates with 100 000 M. canis arthro-
conidia. Medium was replaced each day for five additional
days. To evaluate fungal growth, RFE were processed
for routine histopathology, three serial sections being
performed across the block at 0.1 mm intervals. Results
showed that dimethylsulfoxide had no effect on the growth
of M. canis and cell viability while no fungal growth was
detected in or on infected RFE in the presence of miconazole
concentrations equal to or higher than 0.3 mg L−1 final con-
centration in the culture medium. This study demonstrates
that RFE presents a good permeability to drugs included
in the culture medium and is an adequate model for in vitro
screening of drugs against M. canis and potentially against
other skin pathogens.
Funding: Grant 3.4534.1 from FRSM.
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The concentration time course of 
pradofloxacin in the skin of dogs with 
and without pyoderma
C. R. RESTREPO, S. D. IHRKE, S. D. WHITE, 
I. B. SPIEGEL, V. K. AFFOLTER and R. VULLIET
University of California, Davis, California, USA 
A third-generation fluoroquinolone, pradofloxacin (Bayer
Animal Health, Germany), is being developed to treat
bacterial infections in dogs. This study aimed at comparing
serum and skin concentrations of pradofloxacin in dogs
with pyoderma (affected and non-affected skin) and
normal dogs. Twenty dogs with superficial and/or deep
pyoderma and 20 normal dogs were included in the study.
A complete blood count, biochemical profile and an initial
aerobic skin culture were performed on all dogs with
pyoderma. Pradofloxacin (approximately 3 mg kg−1 of body
weight, per os) was administered daily to all dogs. Serum
and skin biopsy specimens were obtained on day 0 prior
to drug administration and on day 3 (prior to drug adminis-
tration, 2 and 4 h post-drug administration, and in 10 of 20
normal dogs at 24 h post-drug administration). Samples
and tissue specimens were assayed by high-performance
liquid chromatography. Clinical efficacy for dogs with pyo-
derma was recorded at 4 weeks, and again at 6–12 weeks
for dogs with deep pyoderma. Pradofloxacin tissue con-
centrations in lesional skin of dogs with pyoderma were
greater than values for serum and nonlesional skin in the
same group of dogs at 2 h post-drug administration as well
as values for serum and tissue concentrations of normal
control dogs. Clinical efficacy was noted as excellent for dogs
with superficial and deep pyoderma within 4 weeks and
6–12 weeks, respectively. At a mean dosage of 3.7 mg kg−1
per os once daily, pradofloxacin adequately reached
therapeutic tissue concentrations in dogs with pyoderma.
Funding: This study was self-funded.
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Shar-pei dogs with cutaneous 
mucinosis have high serum levels of 
hyaluronic acid
G. ZANNA, F. FONDEVILA, M. BARDAGI, 
M. DOCAMPO, A. BASSOLS and L. FERRER
Universitat Autònoma de Barcelona, Bellatera (Barcelona), 
Spain 
Cutaneous mucinosis (CM) affects a high percentage of
Shar-pei dogs. In a previous communication, we reported
that such mucinosis is the consequence of deposition of
hyaluronic acid (HA) in the dermis of affected animals. The
aim of the present investigation was to correlate HA serum
levels with the presence of CM in Shar-pei dogs, and to
evaluate if this is the result of abnormal hyaluronan
synthesis by dermal fibroblasts. Sera of 21 dogs were used.
Sixteen were Shar-pei dogs, eight were affected by CM
and eight were unaffected, while five were healthy dogs of
other breeds. Serum HA concentration was determined
using a competitive ELISA. A clear positive correlation was
found between the degree of clinical mucinosis and serum
HA concentration. In healthy dogs serum, the average
HA level was of 234.8 µg L−1, whereas in Shar-pei dogs
without or with clinical signs of mucinosis, it was of
532.8 µg L−1 and 1500.7 µg L−1, respectively. Furthermore,
fibroblast cultures from two Shar-pei dogs with clinical
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signs of CM were grown. Morphologically, fibroblasts from
these dogs with CM were similar to those coming from
other breeds although their growth rate was slower. These
results suggest that CM of Shar-pei dogs is a systemic
disease that probably is the consequence of a genetic
defect in the regulation of HA synthesis.
Funding: This study was self-funded.
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A pilot open trial evaluating the efficacy 
of low-dose antifolate therapy with 
aminopterin for treatment of canine 
atopic dermatitis
T. OLIVRY, J. S. PAPS, P. BIZIKOVA, 
K. M. MURPHY and H. A. JACKSON
NC State University College of Veterinary Medicine, 
Raleigh, North Carolina, USA 
In humans, antifolates have been used for decades for
chemotherapy of neoplasia, but they are used currently at
low doses for the treatment of immune diseases including
psoriasis and rheumatoid arthritis. The objective of this
proof-of-concept trial was to explore whether low doses of
the antifolate aminopterin was safe and effective for
treatment of canine atopic dermatitis (AD). Nine dogs with
AD were treated with 0.01 mg kg−1 of aminopterin once
weekly for 4 weeks. Before and after 2 and 4 weeks,
clinicians graded skin lesions using the validated CADESI-
03. At the same times, owners rated the intensity of
pruritic manifestations using a visual analogue scale (PVAS).
Global Scores (GS) combined CADESI and PVAS. Complete
blood counts and serum chemistry panels were obtained
weekly. Eight of nine dogs completed this trial, and one
was withdrawn because of bacterial folliculitis. CADESI and
GS values, but not PVAS numbers, were significantly lower
after 4 weeks compared to pretreatment (ANOVA, P < 0.05).
After 4 weeks, the median reduction in CADESI, PVAS and
GS was 36%, 2.8 out of 10 points and 62%, respectively.
After 1 month, a greater than 50% reduction from baseline
CADESI and GS values was achieved in three of eight and
six of eight dogs, respectively. Adverse effects and clinically
relevant changes in blood counts and chemistry panels
were not seen after aminopterin administration. Results of
this preliminary trial suggest that low-dose antifolates may
be beneficial and safe to treat canine AD. Future studies
should aim at optimizing treatment protocols before
verifying efficacy in randomized controlled trials.
Funding: NC State University Veterinary Teaching
Hospital Clinical Innovation Grant.
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A retrospective study of 21 cases of 
canine atopic-like dermatitis
P. PRELAUD and N. COCHET-FAIVRE
Clinique Advetia, Paris, France 
The revised nomenclature of allergic diseases recently
defined two forms of canine atopic dermatitis (AD): AD
sensu stricto and atopic-like dermatitis (ALD), the latter
characterized by phenotypic AD with no evidence of hyper-
sensitivity to environmental allergens. In the dog, this form
of AD has not been reported yet. The objective of this
study was to compare clinical and epidemiological data
between dogs with AD and ALD. All dogs referred for
evaluation of AD in 2006 were entered in this study. The
diagnosis of AD was made according to Prélaud’s criteria,
elimination of other causes of pruritus and positive
immediate intradermal tests (IDT) to aeroallergens. Canine
ALD was diagnosed clinically as above, but dogs also had
two negative IDT and low level of allergen-specific IgE, and
signs had not responded to an eviction diet of 8 weeks.
Sixty-one dogs were diagnosed with AD and 21 with ALD.
French bulldogs were significantly more often diagnosed
with ALD than with AD. Sex ratios, ages of disease onset,
clinical scores, responses to steroids or anti-infectious
treatment were identical in both diagnosis groups.
Cyclosporine was significantly less effective in dogs with
ALD (50% with good response) than in those with AD
(92% with good response). In summary, French bulldogs
appear predisposed to develop ALD, and this disease may
be less responsive to cyclosporine than AD. As in humans
with ‘intrinsic, nonatopic’ AD, we could document a lack
of predisposition of female patients, a lack of influence of
age of onset and a possible genetic predisposition.
Funding: This study was self-funded.
Friday, 14 September, 15:30
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Monodose allergen-specific 
immunotherapy for treatment of canine 
atopic dermatitis: preliminary safety 
study
N. COCHET-FAIVRE and P. PRELAUD
Clinique Advetia, Paris, France 
Allergen-specific immunotherapy is used for treatment of
canine atopic dermatitis (AD) with human medicine-based
protocols administering progressive doses of allergenic
extracts. A more simple protocol without a dose escalation
phase would greatly simplify the practice of allergen-
specific immunotherapy in the dog. Twenty-six dogs
presented for non-seasonal AD were included in this study.
The diagnosis of AD was based on exclusion of any other
cause of pruritus and fulfilment of four of five major clinical
diagnostic criteria. Immunotherapy formulation was based
on immediate results of intradermal tests showing hyper-
sensitivity to house dust mites. In this monodose protocol,
cetirizine was prescribed at 0.25–0.5 mg kg−1 once daily
for 15 days before the first injection of allergenic extracts
and during 6 months thereafter. Other immune-modulating
treatments were not administered. Immunotherapy injec-
tions consisted of 0.8 mL of alum-precipitated allergenic
extracts (10 IR/mL, Allerbio, Varennes en Argonne, France)
administered subcutaneously once monthly. Using this
protocol, systemic or local reactions were not observed in
any dogs either during the 3 h following allergenic extracts
administration or during the ensuing days. In conclusion,
this monodose protocol combined with cetirizine adminis-
tration appears to be well tolerated in atopic dogs allergic
to house dust mites. This protocol is simple and less
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expensive than traditional or rush protocols. Safety and
efficacy should be verified in larger trials before this
regimen could be recommended for clinical practice.
Funding: This study was self-funded.
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Immunostimulatory oligonucleotides 
modulate canine peripheral blood 
mononuclear cell activity in vitro
A. JASSIES-VANDERLEE*, V. RUTTEN*, 
E. HESSEL†, J. WAGENAAR*, W. VAN EDEN* 
and T. WILLEMSE*
*Faculty of Veterinary Medicine, Utrecht University, 
the Netherlands, †Dynavax Technologies, Berkeley, 
California, USA 
Oligonucleotides rich in CpG exhibit potent immunostimu-
latory activity in humans and various animal species. These
immunostimulatory sequences (ISS) interact with receptors
on cells of both the innate and the specific immune system.
Activation of cells involving Toll-like receptor-9 (TLR-9)
promotes the development of a Th1 response in vitro and
in vivo and prevents cytokine production by allergen-
specific Th2 cells. TLR-9 activating ISS can be given alone
or covalently linked to an antigen; both treatments result
in inhibition of allergen-specific hypersensitivity in animal
models. The effect of ISS on the immune system of dogs, as
exemplified by their effect on in vitro cytokine production
by canine peripheral blood mononuclear cells (PBMC), has
not been determined. PBMCs of five healthy dogs were
incubated for 6 h with ISS classes A, B and C known to
elicit different effects on immune cells due to distinct
structural characteristics. Subsequently, cytokine gene
mRNA transcription was measured by quantitative polymer-
ase chain reaction. Compared to negative controls (control
oligonucleotide and medium), the transcription of IL-6,
IL-10 and IL-12 mRNA was significantly elevated after
stimulation with all three ISS. The expression of TNF-alpha
mRNA increased significantly after stimulation with class
B and C ISS, whereas only class C ISS resulted in enhanced
expression of interferon-gamma mRNA. It is concluded
that ISS have a modulating effect on PBMC of healthy dogs
in vitro as in mice, primates and humans. Therefore, like
in mice with experimentally induced allergic asthma,
ISS may be a promising tools for modulation of atopic
dermatitis in dogs.
Funding: University of Utrecht.
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Cytological diagnosis of nodular 
dermatophytosis (kerion) in dogs: 
preliminary results
L. C. CORNEGLIANI* and S. C. COLOMBO†
*Ambulatorio Veterinario Associato, Torino, Italy, 
†Legnano, Italy 
Dermatophytosis is a disease with zoonotic potential,
and as such, an early diagnosis is required. Wood’s lamp
examination and microscopic examination of hair plucks
are diagnostic in 40–70% of cases. Fungal culture is reli-
able, but it takes longer and can yield false-negative results.
In nodular dermatophytosis, these tests can be negative
and histopathological examination with special stains
(periodic acid–Schiff) is required. The aim of this preliminary
study is to assess the usefulness of cytology in the diag-
nosis of canine nodular dermatophytosis. Ten dogs of dif-
ferent age, sex and breed with nodular lesions suggestive
of dermatophytic kerion were selected. Wood’s lamp
examination, microscopic examination of hair plucks and
fungal cultures were performed in all cases; impression
smears from the nodular lesions obtained by squeezing
the lesion were stained with a modified Romanowsky
stain (Hemacolor). Wood’s lamp examination was negative
in all cases. Microscopic examination of hair plucks
suggested dermatophytosis in four of 10 dogs. Fungal
culture was positive for Microsporum canis in eight of
10 dogs. Cytological examination was suggestive of a
pyogranulomatous lesion. Small fragments of hair shafts
with arthrospores were easily detected in samples from all
10 dogs. In this study, cytology results were suggestive of
dermatophytosis in all cases, while the other tests were not
always diagnostic. Further studies should be performed to
verify these findings in a larger group of dogs.
Funding: This study was self-funded.
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Chronic radiant heat dermatitis in the 
dog: a report of four severe cases
A. MULLER*, E. GUAGUERE* and 
F. DEGORCE-RUBIALES†
*Clinique Saint Bernard, Lomme, France, †LAPVSO, 
Blagnac, France 
Chronic radiant heat dermatitis (CRHD) is a rare dermato-
logical condition characterized by erythematous, reticular
often-pigmented lesions resulting from repeated or pro-
longed exposure to infrared radiation. Our objective was to
report four canine cases with severe CRHD. The mean age
of affected dogs was 7.5 years (range 6–10 years). A breed
predisposition was not observed. Heat sources included
heat lamp (one case) or open fires (three cases). The
duration of exposure to radiant head varied from 6 to
18 months. Concurrent hypothyroidism was diagnosed in
two dogs that presented lethargy and obesity. Lesions of
CRHD were on the lateral thorax (two cases) and flanks
(two cases). Clinical signs included irregular branching
alopecia (resembling ‘prehistoric paintings’) with erythema
(three cases), scaling (one case), central depigmentation
(three cases), and central (one case) or peripheral hyper-
pigmentation (two cases). Central or linear peripheral
erosions or ulcerations were observed in three dogs. Pain
and increased skin thickness were noted in two cases.
Histopathological features from non-ulcerated affected
areas revealed a cell-poor interface dermatitis with
sub-epidermal bubbling vacuolation, smudging of dermal
collagen, and dyskeratotic and apoptotic keratinocytes.
Eosinophilic wavy fibrils in the superficial dermis were
identified in all cases. Histopathological lesions of ulcerated
areas were typical of concurrent thermal burns. A medical
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treatment was not given except for levothyroxine in dogs
with concurrent hypothyroidism. Heat avoidance was
recommended, and cicatricial alopecia developed in three
cases.
Funding: This study was self-funded.
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Prevalence of serum antibodies against 
canine papillomaviruses in two 
geographically distinct regions
C. LANGE*, K. TOBLER*, C. FAVROT*, 
J. O. NÖTHLING† and M. ACKERMANN*
*Vetsuisse Faculty, University of Zürich, Zürich, 
Switzerland, †Faculty of Veterinary Science, 
University of Pretoria, Pretoria, South Africa 
Papillomaviruses (PVs) rank among the main causative
agents for the development of certain types of tumours in
humans, mainly cervical carcinomas and epidermodysplasia
verruciformis (EV). The role of PVs in the development of
cancers in the canine species remains controversial,
however. We recently described the characterization
and sequencing of a new canine PV (CPV3), which had
been isolated from a dog suffering of a disease resembling
human EV. In this study, we investigated the distribution
and possible relevance of CPV3 in two geographically dis-
tinct regions. Since ELISA is commonly used in prevalence
studies in human medicine, we established a generic
capture ELISA to screen 232 sera from Switzerland and
315 sera from South Africa for the presence of antibodies
against the major capsid proteins L1 of CPV3 as well as
COPV. Our tests revealed a much higher seropositivity in
the South African compared to the Swiss population and
also a different distribution. In the Swiss population, most
positive sera reacted only to COPV. In contrast, in the
South African population, we found not only much more
CPV3-positive reacting dogs but also a high proportion of
sera containing antibodies against both CPV3 and COPV
antigens. The results therefore indicate that CPV3 is a
common virus among the tested population in South Africa
and also, but to a lesser extend, in the tested Swiss
population. They furthermore suggest that the rate of
canine PV infections as well as the role of certain PVs might
depend on the geographical region.
Funding: this study was self-funded.
Saturday, 15 September, 17:15.
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Isolation and sequencing of a novel 
papillomavirus associated with 
pigmented plaques in four pugs
C. FAVROT*, K. TOBLER*, C. LANGE*, 
D. N. CARLOTTI† and M. ACKERMANN*
*Vetsuisse Faculty, University of Zürich, Zürich, 
Switzerland, †Aquivet Clinique Vétérinaire, Service de 
Dermatologie, Eysines, France 
Canine pigmented plaque (CEP) is a skin disorder charac-
terized by multiple black papules or plaques on the abdominal
area or limbs. This disorder was first described in pugs in
which it was initially called lentiginosis profusa. This breed
appears to be highly predisposed to developing such
lesions but cancerization was never reported. On the other
hand, a similar condition was reported in non-pug dogs
with a very high rate of cancerization. The association of
CEP with papillomavirus infection has been reported in
several studies. In the present study, we report four new
cases of CEP in pugs. Taking advantage of the circular DNA
of papillomaviruses, we carried out rolling circle amplifica-
tion of the viral genome. Sequencing of the entire genome
revealed that the CEP-associated papillomavirus was
related to a recently cloned virus isolated from a similar
lesion in a Rhodesian ridgeback (CPV3). Using polymerase
chain reaction, we demonstrated that all pugs were
infected by similar viruses. Interestingly, our sequencing
data match those of small sequences of papillomavirus
DNA isolated from Japanese pug lesions. It seems likely
therefore that pugs affected with CEP are infected with
one or several closely related papillomavirus(es). This new
virus type is different from CPV3 but belongs to the same
genus. Papillomavirus is often detected in lesions of CEP
and probably plays a role in the development of such
lesions. Further studies are warranted to firmly establish
such causality, however.
Funding: This study was partially funded by the
Waltham foundation and the European Society of
Veterinary Dermatology.
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The influence of polyunsaturated fatty 
acids on cytokine gene transcription by 
peripheral blood mononuclear cells in 
normal dogs and dogs with atopic 
dermatitis
M. E. STEHLE, T. GÖBEL, M. HANCZARUK, 
S. REHFELD and R. S. MUELLER
Ludwig Maximilian Universität, Munich, Bavaria, Germany 
Ten dogs with atopic dermatitis diagnosed based on
Willemse’s criteria, exclusion of differential diagnoses and
positive skin reactivity against Dermatophagoides farinae
(Df ) antigens and 10 healthy control dogs were included
in this study. Blood was obtained by venipuncture, and
peripheral blood mononuclear cells were isolated. Cells
were stimulated for 24 h with allergen diluent (negative
control) or 50 µg mL−1 of a specific Df extract with or
without three different polyunsaturated fatty acid (PUFA)
combinations: alpha-linolenic acid (ALA), eicosapentaenoic
acid (EPA)/docosahexaenoic acid (DHA) and gamma-
linoleic acid (GLA)/EPA/DHA. RNA was isolated and
quantitative polymerase chain reaction was performed for
interferon (IFN)-gamma, interleukin (IL)-4 and transforming
growth factor-beta. In atopic and healthy dogs, there was
up-regulation of IL-4 and IFN-gamma mRNA transcription
after incubation with Df allergen. This allergen-induced up-
regulation was not reversed by incubation with PUFA from
either group. However, in atopic dogs this up-regulation
was increased with GLA/EPA/DHA (P < 0.01 compared
to controls); in healthy dogs it was with ALA (P < 0.01).
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TGF-beta mRNA transcription was not significantly altered
in atopic dogs, but it was significantly decreased in healthy
dog cells after culture with EPA/DHA (P < 0.001). Based on
the results of this study, Df extract leads to the up-regulation
of IL-4 and IFN-gamma mRNA transcription in peripheral
blood mononuclear cells of atopic and healthy dogs
but PUFAs do not inhibit either IL-4 or IFN-gamma gene
transcription.
Funding: Boehringer Ingelheim Denmark.
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Emergence of multiresistant 
mecA-positive Staphylococcus 
intermedius isolated from canine and 
feline pyoderma and otitis in Europe
A. LOEFFLER*, M. LINEK†, A. MOODLEY‡, 
L. GUARDABASSI‡, J. M. L. SUNG§, 
M. WINKLER¶, R. WEISS** and D. H. LLOYD*
*Department of Veterinary Clinical Sciences, Royal 
Veterinary College, University of London, London, UK, 
†Tierärztliche Spezialisten, Hamburg, Germany, 
‡Department of Veterinary Pathobiology, University of 
Copenhagen, Frederiksberg, Denmark, §Department of 
Cellular and Molecular Medicine, St. George’s University 
of London, London, UK, ¶Institut für Hygiene und 
Infektionskrankheiten der Tiere, Justus-Liebig-Universität, 
Giessen, Germany, **Veterinärmedizinisches 
Analysenzentrum, Geesthacht, Germany 
Resistance to cephalosporins and/or fluoroquinolones in
Staphylococcus intermedius has until now remained low
in Europe, with drugs generally remaining effective for
systemic therapy in dogs and cats. This study describes
clinical and epidemiological features of skin and ear infection
in 11 dogs and one cat with highly resistant S. intermedius
referred to a veterinary dermatology clinic in Northern
Germany. In addition, phenotypic and genotypic character-
istics of the isolates are described. Twelve S. intermedius
resistant to at least five antimicrobial classes were isolated
from samples of skin and ear infections submitted to
veterinary diagnostic laboratories. They represented 23%
of all S. intermedius submissions during an 18-month
period, and resistance included cephalexin, methicillin
and enrofloxacin. Species identification was confirmed by
PCR detection of thermonuclease genes (nuc). Presence
and expression of the gene conferring resistance to all
betalactam antibiotics (mecA) were demonstrated in all
S. intermedius. Based on pulsed-field gel electrophoresis,
six were indistinguishable and the others closely or possibly
related. Diagnoses at referral had been recurrent superficial
pyoderma, deep pyoderma, pododermatitis and chronic
otitis, all unresponsive to systemic betalactam antibiotics or
fluoroquinolones. Eleven animals responded to treatment
within 8 weeks. Topical therapy, as the only antimicrobial
treatment, was successful in six cases. The emergence of
multiresistant, mecA-positive S. intermedius in Europe is
alarming. Zoonotic implications, awareness among veterinary
laboratories and strategies for the use of antimicrobials in
small animal practice need to be considered.
Funding: This study was self-funded.
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Immunohistochemical detection of 
filaggrin in the skin of different species
M. BARDAGÍ*, H. VALA†, D. FONDEVILA* 
and L. FERRER*
*Universitat Autònoma de Barcelona, Barcelona, Spain, 
†Escola Superior Agrária de Viseu, Campus Politécnico, 
Portugal 
Filaggrin (FLG) is a protein that facilitates terminal differen-
tiation of epidermal cells and formation of the skin barrier.
Recent studies have demonstrated that, in humans, muta-
tions encoding FLG are a major genetic predisposing factor
for atopic dermatitis. Furthermore, in immunohistochemical
studies, FLG’s staining intensity was found to be markedly
reduced both in nonlesional and in lesional atopic human
skin. The aim of this project was to investigate, using
immunohistochemistry, the expression of FLG in the skin
of the dog, goat, sheep, cow and pig in preparation for
future investigations of FLG expression in canine atopic
skin. Formalin-fixed paraffin-embedded sections were
stained using an ABC immunohistochemical technique.
A polyclonal antibody against human pro-FLG (Zymed
Laboratories) was used as primary antibody. Filaggrin stain-
ing was consistent in all species. Filaggrin was detected
clearly in the epidermal granular layer of all studied animals,
except for that of the thorax area of the goat. The outer root
sheath of the hair follicles also was stained. The staining
in all cases was cytoplasmic and keratohyalin granules
strongly stained positive. These results are very similar to
those described in human beings and they open the door to
further studies regarding the expression of FLG in animals
with skin diseases.
Funding: this study was self-funded.
